Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.
Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the capability into the familiar Gen5 software environment, the module is designed to reduce manual image-analysis steps and support consistent cell counting and confluence analysis across supported applications.
Conventional threshold-based segmentation can require researchers to establish and optimize analysis parameters for individual experiments.
These additional steps can introduce user-dependent variation and present challenges as laboratories adopt higher-throughput imaging workflows and generate increasing volumes of image-based data.
The Gen5 AI image analysis module provides researchers with an AI-based approach designed to simplify this process within their established BioTek imaging workflow.
A shares gained $1.54 to $176.74.
